vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-631Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL OBSERVATIONSГипертрофическая кардиомиопатия в структуре врожденных полиорганных синдромов у пациентов раннего детского возрастаHYPERTROPHIC CARDIOMYOPATHY AS A PART OF INHERITED MALFORMATION SYNDROMES IN INFANTSТуральчукМ.В.Tural'chukM.V.ten_puppies@mail.ruНовикГ.А.NovikG.A.neonatepearl@yandex.ruГудковаА.Я.GudkovaA.Ya.neonatepearl@yandex.ruСанкт-Петербургская государственная педиатрическая медицинская академияSt.-Petersburg State Pediatric Medical AcademyСанкт-Петербургский государственный медицинский университет им. И.П. ПавловаI.P. Pavlov St.-Petersburg State Medical University201116052011103Вопросы современной педиатрии166–169Copyright © Туральчук М., Новик Г., Гудкова А., 20112011Туральчук М., Новик Г., Гудкова А.Tural'chuk M., Novik G., Gudkova A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/631ReferencesMaron В.J., McKenna W.J. et al. ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy. JACC. 2003; 42: 1–27.Maron В.J., McKenna W.J. et al. ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy. JACC. 2003; 42: 1–27.Keren А., Syrris Р., McKennaW.J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5 (3): 158–168.Keren А., Syrris Р., McKennaW.J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5 (3): 158–168.Colan S.D., Lipshultz S.E., Lowe A.M. et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children findings from the pediatric cardiomyopathy registry. Circulation. 2007; 115: 773–781.Colan S.D., Lipshultz S.E., Lowe A.M. et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children findings from the pediatric cardiomyopathy registry. Circulation. 2007; 115: 773–781.Hoffmann B., Mayatepek E. Fabry disease-often seen, rarely diagnosed. Dtsch. Arztebl. Int. 2009; 106 (26): 440–447.Hoffmann B., Mayatepek E. Fabry disease-often seen, rarely diagnosed. Dtsch. Arztebl. Int. 2009; 106 (26): 440–447.Veinot J.P. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002; 106 (15): 1407–1411.Veinot J.P. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002; 106 (15): 1407–1411.Chimenti C., Pieroni M. et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004; 110 (9): 1047–1053.Chimenti C., Pieroni M. et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004; 110 (9): 1047–1053.Maron В.J., Seidman C.E., Ackerman M.J. et al. How should hypertrophic cardiomyopathy be classified? What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ. Cardiovasc. Genet. 2009; 2 (1): 81–85.Maron В.J., Seidman C.E., Ackerman M.J. et al. How should hypertrophic cardiomyopathy be classified? What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ. Cardiovasc. Genet. 2009; 2 (1): 81–85.Wilkinson J.D., Sleeper L.A., Alvarez J.A. еt al. The Pediatric Cardiomyopathy Registry: 1995–2007. Prog. Pediatr. Cardiol. 2008; 25 (1): 31–36.Wilkinson J.D., Sleeper L.A., Alvarez J.A. еt al. The Pediatric Cardiomyopathy Registry: 1995–2007. Prog. Pediatr. Cardiol. 2008; 25 (1): 31–36.Gelb B.D., Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 2006; 15 (2): 220–226.Gelb B.D., Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 2006; 15 (2): 220–226.Digilio M.C., Conti E., Sarkozy A. et al. Grouping of multiple lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet. 2002; 71 (2): 389–394.Digilio M.C., Conti E., Sarkozy A. et al. Grouping of multiple lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet. 2002; 71 (2): 389–394.Sarkozy A., Conti E., Digilio M.C. et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J. Med. Genet. 2004; 41 (5): e68.Sarkozy A., Conti E., Digilio M.C. et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J. Med. Genet. 2004; 41 (5): e68.Sarkozy A., Digilio M.C., Dallapiccola B. Leopard syndrome. Orphanet J. Rare Dis. 2008; 3: 1–8.Sarkozy A., Digilio M.C., Dallapiccola B. Leopard syndrome. Orphanet J. Rare Dis. 2008; 3: 1–8.Allanson J.E. Noonan syndrome. Am. J. Med. Genet. C. Semin. Med. Genet. 2007; 145: 274–279.Allanson J.E. Noonan syndrome. Am. J. Med. Genet. C. Semin. Med. Genet. 2007; 145: 274–279.Gibson W., Trevenen C., Giuffre M., Leung A.K. Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy. J. Natl. Med. Assoc. 2005; 97 (6): 805–807.Gibson W., Trevenen C., Giuffre M., Leung A.K. Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy. J. Natl. Med. Assoc. 2005; 97 (6): 805–807.Cerrato F., Pacileo G., Limongelli G. et al. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes. Cardiol. Young. 2008; 18 (6): 575–580.Cerrato F., Pacileo G., Limongelli G. et al. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes. Cardiol. Young. 2008; 18 (6): 575–580.Formigari R., Michielon G., Digilio M.C. et al. Genetic syndromes and congenital heart defects: how is surgical management affected? Eur. J. Cardiothorac. Surg. 2009; 35 (4): 606–614.Formigari R., Michielon G., Digilio M.C. et al. Genetic syndromes and congenital heart defects: how is surgical management affected? Eur. J. Cardiothorac. Surg. 2009; 35 (4): 606–614.Arad M., Maron B.J., Gorham J.M. et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 2005; 352 (4): 362–372.Arad M., Maron B.J., Gorham J.M. et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 2005; 352 (4): 362–372.
The authors declare that there are no conflicts of interest present.